Capital Research Global Investors increased its holdings in shares of Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO) by 20.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 529,699 shares of the basic materials company’s stock after acquiring an additional 90,948 shares during the period. Capital Research Global Investors’ holdings in Cameco were worth $48,503,000 at the end of the most recent reporting period.
Several other hedge funds have also bought and sold shares of the business. Legal & General Group Plc lifted its stake in shares of Cameco by 4.6% in the third quarter. Legal & General Group Plc now owns 2,483,216 shares of the basic materials company’s stock worth $208,450,000 after buying an additional 108,841 shares in the last quarter. SHEPHERD WEALTH MANAGEMENT Ltd LIABILITY Co bought a new position in shares of Cameco in the fourth quarter worth approximately $1,974,000. Caprock Group LLC bought a new position in shares of Cameco in the third quarter worth approximately $1,066,000. Intech Investment Management LLC lifted its stake in shares of Cameco by 3.8% in the third quarter. Intech Investment Management LLC now owns 500,699 shares of the basic materials company’s stock worth $42,031,000 after buying an additional 18,261 shares in the last quarter. Finally, Vanguard Group Inc. lifted its stake in shares of Cameco by 1.5% in the fourth quarter. Vanguard Group Inc. now owns 18,059,335 shares of the basic materials company’s stock worth $1,653,639,000 after buying an additional 258,193 shares in the last quarter. Institutional investors own 70.21% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on CCJ shares. Zacks Research downgraded shares of Cameco from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 18th. Glj Research reiterated a “buy” rating and issued a $171.20 target price (up from $100.00) on shares of Cameco in a research note on Wednesday, February 18th. Scotiabank reiterated an “outperform” rating and issued a $175.00 target price on shares of Cameco in a research note on Wednesday, May 6th. Weiss Ratings downgraded shares of Cameco from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, June 4th. Finally, William Blair started coverage on shares of Cameco in a research note on Monday, April 20th. They issued an “outperform” rating on the stock. Eleven analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $148.62.
Cameco Stock Down 3.2%
Shares of CCJ stock opened at $102.10 on Wednesday. Cameco Corporation has a 12 month low of $62.59 and a 12 month high of $135.24. The stock has a market cap of $44.47 billion, a P/E ratio of 94.54, a P/E/G ratio of 1.79 and a beta of 0.99. The company has a current ratio of 3.08, a quick ratio of 2.09 and a debt-to-equity ratio of 0.14. The company has a 50 day simple moving average of $113.68 and a two-hundred day simple moving average of $108.92.
Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) last announced its earnings results on Tuesday, May 5th. The basic materials company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.05. Cameco had a net margin of 18.38% and a return on equity of 11.05%. The business had revenue of $607.49 million during the quarter, compared to analysts’ expectations of $598.63 million. During the same period in the prior year, the company earned $0.16 earnings per share. The firm’s revenue was up 7.1% on a year-over-year basis. On average, research analysts expect that Cameco Corporation will post 1.31 earnings per share for the current year.
Cameco Company Profile
Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.
The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.
Featured Stories
- Five stocks we like better than Cameco
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO).
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.
